Pharmaceutical Published Insights

Published Date : 23 Jan, 2026

The global pharmaceutical chemicals market is estimated to be valued at USD 147.97 Bn in 2025 and is expected to exhibit a CAGR of 7.4% during the forecast period (2025-2032). Pharmaceutical chemicals are chemical substances or a combination of substances that are u... View more

Published Date : 23 Jan, 2026

Global Barrett’s esophagus market is estimated to be valued at USD 5.32 Bn in 2025 and is expected to reach USD 7.70 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032. Barrett's esophag... View more

Published Date : 23 Jan, 2026

The H2 receptor antagonist Market is estimated to be valued at USD 4.48 Bn in 2025 and is expected to reach USD 6.87 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032. H2 receptor antagonists... View more

Published Date : 23 Jan, 2026

Medicinal mushrooms have been utilized for centuries as traditional remedies and tonics across various Eastern cultures. These mushrooms are now gaining popularity worldwide due to their purported health benefits and immunomodulatory properties. Key medicinal mushroom... View more

Published Date : 23 Jan, 2026

Skin rashes affect people of all age groups and can occur due to various reasons such as allergies, infections, change in climate etc. Skin rashes cause severe itching, redness and inflammation on the skin. The skin rash treatment market offers a wide range of product... View more

Published Date : 23 Jan, 2026

The incretin mimetics market is estimated to be valued at USD 23.84 Bn in 2025 and is expected to reach USD 33.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032. Incretin mimetics are a cl... View more

Published Date : 23 Jan, 2026

The antihistamine drugs market is estimated to be valued at USD 101.74 Bn in 2025 and is expected to reach USD 167.80 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032. Antihistamine drugs are a ... View more

Published Date : 23 Jan, 2026

The ethical pharmaceuticals market is estimated to be valued at USD 5.26 Bn in 2025 and is expected to reach USD 10.59 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032. The ethical pharmace... View more

Published Date : 23 Jan, 2026

The paclitaxel injection market is estimated to be valued at USD 7.15 Bn in 2025 and is expected to reach USD 16.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032. The paclitaxel injectio... View more

Published Date : 23 Jan, 2026

The global Sever's Disease Treatment Market is estimated to be valued at USD 1.41 Bn in 2025 and is expected to reach USD 2.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032. Sever's disea... View more

Published Date : 23 Jan, 2026

The global uterine fibroids treatment drugs market is estimated to be valued at USD 2.02 Bn in 2025 and is expected to exhibit a CAGR of 8.1% during the forecast period (2025-2032). Uterine fibroids are non-cancerous tumors that grow in or on a woman's uterus. Sympt... View more

Published Date : 23 Jan, 2026

Global non opioid pain treatment market is estimated to be valued at USD 85.84  billion in 2025 and is expected to reach USD 155.01 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032. ... View more

Published Date : 23 Jan, 2026

The medical second opinion market is estimated to be valued at USD 8.30 Bn in 2025 and is expected to reach USD 24.18 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.5% from 2025 to 2032. The global medical se... View more

Published Date : 23 Jan, 2026

Global cosentyx drug market is estimated to be valued at USD 5.72 Bn in 2025, and is expected to reach USD 9.50 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032. Cosentyx (secukinumab) is a ... View more

Published Date : 23 Jan, 2026

The Lenalidomide Drug Market is estimated to be valued at USD 14.08 Bn in 2025 and is expected to reach USD 22.04 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. Lenalidomideis an immunomo... View more

Published Date : 23 Jan, 2026

Global human insulin drug market is estimated to be valued at USD 57.04 Bn in 2025, and is expected to exhibit a CAGR of 8.7% during the forecast period (2025-2032). Global human insulin drug market has been witnessing steady growth over the past few years, owing to... View more

Published Date : 23 Jan, 2026

Global targeted drug delivery market is estimated to be valued at USD 10.72 Bn in 2025, and is expected to exhibit a CAGR of 16.3% during the forecast period (2025-2032). Targeted drug delivery refers to the delivery of pharmaceutical compounds directly to the targe... View more

Published Date : 23 Jan, 2026

Treatment resistant depression (TRD) is a widespread mental health condition wherein patients do not respond adequately to standard antidepressant medications. TRD affects approximately 30% to 50% of patients with major depressive disorder. The exact causes that lead ... View more